LORICRIN and inflammatory skin disease: As expected in an inflammatory skin disease, both AD and psoriasis models showed disturbed epidermal differentiation with decreased protein and mRNA expression of the late keratinocyte differentiation markers filaggrin (FLG) (Fig. 2B) and loricrin (Fig. 2C).